In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Animal health and oncology deal activity is heating up in 2017.
The $5.2 billion takeout of Ariad Pharma was the biggest news from the closely followed healthcare conference.
The companies will study epacadostat in tandem with Merck's Keytruda in patients with non-small cell lung, renal, bladder and head and neck cancers.
Deals, though, weren't the only mover of share prices.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.